Sodelglitazar
Alternative Names: 677954; GSK 677954; GW677954Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator GlaxoSmithKline
- Class Antihyperglycaemics; Insulin sensitisers
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia; Metabolic syndrome; Type 2 diabetes mellitus
Most Recent Events
- 28 Feb 2007 Phase-II clinical trials in Hyperlipidaemia in World (PO)
- 28 Feb 2007 Phase-II clinical trials in Metabolic syndrome in World (PO)
- 05 Dec 2003 Phase-II clinical trials in Type-2 diabetes mellitus in USA (PO)